Thermo_Apr2021_The_mRNA_TherapeuticsBoom - 1

Photo: Getty Images, NANOCLUSTERING/SCIENCE PHOTO LIBRARY

How to
Simplify
Workflows and
Maximize the
Efficiency of the
mRNA Purification
Process with
POROS™ Oligo
(dT)25 Affinity
Resin.
A S P O N S O R E D P U B L I C AT I O N F R O M

The mRNA
Therapeutics
Boom
Scalable Purification of
InVitro Transcribed mRNA
Accelerates mRNA-Based
Therapy Development

mRNA

is beautifully simple; it provides your
body instructions. Analogous to
computer code, mRNA programs the body to produce
specific proteins giving this molecule utility in a myriad
of therapeutic approaches, including vaccines against
common and rare infectious diseases, oncology indications, and protein replacement treatments for genetic
disorders. The wide diversity of mRNA-based therapeutic applications has led to increased interest in
using synthetic mRNA.

In the early 90s, scientists demonstrated efficacy when using mRNA
as a potential therapy.1,2 But interest in antibodies, whose potential
was more broadly accepted, took over in prominence. Today, mRNA

© Gen Publishing - April 2021



https://www.genengnews.com https://www.thermofisher.com/us/en/home.html

Thermo_Apr2021_The_mRNA_TherapeuticsBoom

Table of Contents for the Digital Edition of Thermo_Apr2021_The_mRNA_TherapeuticsBoom

Thermo_Apr2021_The_mRNA_TherapeuticsBoom - 1
Thermo_Apr2021_The_mRNA_TherapeuticsBoom - 2
Thermo_Apr2021_The_mRNA_TherapeuticsBoom - 3
Thermo_Apr2021_The_mRNA_TherapeuticsBoom - 4
Thermo_Apr2021_The_mRNA_TherapeuticsBoom - 5
https://www.nxtbookmedia.com